Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium in Aneurysmal Subarachnoid Haemorrhage
ISRCTN68742385Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Magnesium sulphate with Placebo (2 arms). Primary endpoint: Poor outcome at 3 months. Started Jan 2006; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on ISRCTN68742385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN68742385.